Access cutting-edge atrial fibrillation (af) treatment through this clinical trial at a research site in Pensacola. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Pensacola location
Preparing your pre-screening questions…
Access atrial fibrillation (af) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation (af) treatment provided free
Check if you qualify for this atrial fibrillation (af) clinical trial in Pensacola, FL
No-Cost Study Care
Local to Pensacola
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can slow down or pool in one spot, which can lead to the formation of blood clots. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation. The aim of the study is to see how effective and safe REGN7508 and REGN9933, individually, are in preventing ischemic stroke or systemic embolism in people with atrial fibrillation who cannot or may choose to not take blood thinners. The study is looking at several other research questions, including: * What side effects may happen from taking REGN7508 or REGN9933 * How well does REGN7508 or REGN9933 lower the risk of having an ischemic stroke and/or systemic embolism compared to the placebo * How well does REGN7508 or REGN9933 lower the risk of having a major health problem affecting heart and blood circulation compared to placebo * How well does REGN7508 or REGN9933 lower the risk of death compared to placebo * How much REGN7508 or REGN9933 is in the blood at different times * Whether the body makes antibodies against REGN7508 or REGN9933 (which could make the study drugs less effective or could lead to side effects)
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07430956) has an active research site in Pensacola, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for atrial fibrillation (af) treatment options in Pensacola, FL, this clinical trial (NCT07430956) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pensacola research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation (af) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all atrial fibrillation (af) clinical trials near you to find additional studies recruiting in your area.
See all atrial fibrillation clinical trials recruiting in Pensacola — not just this study.
Browse Atrial Fibrillation Trials in Pensacola →